CuraTeQ Biologics
- Biotech or pharma, therapeutic R&D
- CMO, CRO
𝗖𝘂𝗿𝗮𝗧𝗲𝗤 𝗕𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝘀 (an Aurobindo Pharma company) is an 𝗘𝗨 𝗚𝗠𝗣 𝗰𝗲𝗿𝘁𝗶𝗳𝗶𝗲𝗱 biopharmaceutical company based in Hyderabad, India.
CuraTeQ has a development pipeline of 14 biosimilars. Three products have been filed with EMA, one product with MHRA, and four products are in global PhIII clinical trials.
- 𝗕𝗲𝘃𝗾𝗼𝗹𝘃𝗮® (Bevacizumab biosimilar) has received MHRA approval.
- 𝗗𝘆𝗿𝘂𝗽𝗲𝗴® (Pegfilgrastim biosimilar) has received EMA approval.
- 𝗭𝗲𝗳𝘆𝗹𝘁𝗶® (Filgrastim biosimilar) has received EMA approval.
- 𝗗𝗮𝘇𝘂𝗯𝗹𝘆𝘀® (Trastuzumab biosimilar) has received CHMP positive opinion, and CDSCO approval in India.
𝗢𝘂𝗿 𝗔𝗳𝗳𝗶𝗹𝗶𝗮𝘁𝗲𝘀 𝗮𝗻𝗱 𝗦𝗲𝗿𝘃𝗶𝗰𝗲 𝗼𝗳𝗳𝗲𝗿𝗶𝗻𝗴𝘀:
- 𝗔𝘂𝗿𝗼 𝗣𝗲𝗽𝘁𝗶𝗱𝗲𝘀, our synthetic peptide API manufacturing arm, has filed 14 DMFs with US FDA contributing to 6 ANDA approvals and 2 CEP approvals.
- 𝗖𝗗𝗠𝗢 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀: we offer wide range of CDMO services across biologics, peptides, vaccines and oligonucleotides.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}